Patent · US Active

Compounds for preparing immunological adjuvant

US8519170B2 · kind B2 · utility

1Cited by
6References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 10, 2012
Grant dateAug 27, 2013
Priority date—
Expiry dateMay 10, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides methods for preparing TLR-4 receptor agonist E6020:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.